2m 2m 2m 2m 2m 2m 2m
ELEDON PHARMA (ELDN)
NASDAQ
$2.50+$0.06 (+2.67%)
Price as of Oct 02, 2026 5:46 PM EDT- $197.9MMarket Cap
- -11.78%1-Year Change
- BiotechnologyIndustry
ELEDON PHARMA (ELDN)
$2.50+$0.06 (+2.67%)
ELDN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.44 | ||
Change | -$0.09 (-3.75%) | ||
Open | $2.52 | ||
High | $2.55 | ||
Low | $2.42 | ||
Previous Close | $2.53 | ||
Volume | 616,502 | ||
30-Day Average Volume | 900,993 | ||
1-Week Change | -9.14% | ||
1-Month Change | -19.10% | ||
1-Year Change | -11.78% | ||
3-Year Change | 77.74% | ||
5-Year Change | -59.42% | ||
Fundamentals | |||
Shares Outstanding | 81.3M | ||
Total Assets | $126.1M | ||
Market Cap | $197.9M | ||
Enterprise Value | $191.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$31.6M | ||
Free Cash Flow | -$22.7M | ||
EBIT | -$31.6M | ||
EBITDA | -$31.6M | ||
Net Working Capital | $81.3M | ||
EPS | -$0.27 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -9 | ||
PEG | -0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 18 | ||
Last Split Date | 10/05/2020 | ||
Earnings & Revenue